These findings, although limited to ACTH-dependent causes of CS, support our hypothesis that FKBP5 can serve as a measure of cortisol biological activity and set the stage for the development of FKBP5 mRNA expression as a potential biomarker of cortisol activity in patients with CS. This evidence concerns the gene POMC and Cowden syndrome 1.